Some of the identified prognostic DE RBPs have been reported associated with tumor progression, such as RBM47, LUZP4, AFF3, PPARGC1A, PPARGC1B, PABPC3, and PNLDC1. This evidence concerns the gene AFF3 and neoplasm.